1
|
Poinard S, Dorado Cortez O, François M, Gain P, Thuret G. [Tamoxifen-related macular hole: Choice of surgical approach]. J Fr Ophtalmol 2023; 46:e338-e342. [PMID: 37634962 DOI: 10.1016/j.jfo.2023.04.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Revised: 04/14/2023] [Accepted: 04/26/2023] [Indexed: 08/29/2023]
Affiliation(s)
- S Poinard
- Laboratoire Biologie imagerie ingénierie pour l'ophtalmologie (BiiO), faculté de médecine, campus Santé Innovation, université Jean-Monnet, 10, rue de Marandière, 42270 Saint-Priest-en-Jarez, France; Service d'ophtalmologie, CHU de Saint-Étienne, avenue Albert-Raimond, 42055 Saint-Étienne cedex 1, France.
| | - O Dorado Cortez
- Laboratoire Biologie imagerie ingénierie pour l'ophtalmologie (BiiO), faculté de médecine, campus Santé Innovation, université Jean-Monnet, 10, rue de Marandière, 42270 Saint-Priest-en-Jarez, France; Service d'ophtalmologie, CHU de Saint-Étienne, avenue Albert-Raimond, 42055 Saint-Étienne cedex 1, France
| | - M François
- Service d'ophtalmologie, CHU de Saint-Étienne, avenue Albert-Raimond, 42055 Saint-Étienne cedex 1, France
| | - P Gain
- Laboratoire Biologie imagerie ingénierie pour l'ophtalmologie (BiiO), faculté de médecine, campus Santé Innovation, université Jean-Monnet, 10, rue de Marandière, 42270 Saint-Priest-en-Jarez, France; Service d'ophtalmologie, CHU de Saint-Étienne, avenue Albert-Raimond, 42055 Saint-Étienne cedex 1, France
| | - G Thuret
- Laboratoire Biologie imagerie ingénierie pour l'ophtalmologie (BiiO), faculté de médecine, campus Santé Innovation, université Jean-Monnet, 10, rue de Marandière, 42270 Saint-Priest-en-Jarez, France; Service d'ophtalmologie, CHU de Saint-Étienne, avenue Albert-Raimond, 42055 Saint-Étienne cedex 1, France
| |
Collapse
|
2
|
Erbahçeci Timur İE, Açıkgöz V, Uğurlu N, Yalçın B, Şendur MAN, Hızal M, Kara H. Tamoxifen related chorioretinal structural changes. Cutan Ocul Toxicol 2023; 42:109-117. [PMID: 37272809 DOI: 10.1080/15569527.2023.2220388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2023] [Revised: 04/25/2023] [Accepted: 05/27/2023] [Indexed: 06/06/2023]
Abstract
PURPOSE To evaluate the vascular structure of the choroid and each retinal layer in patients with breast cancer on tamoxifen therapy and compare them with healthy subjects. MATERIALS AND METHODS 124 eyes of 62 patients with breast cancer who were on tamoxifen therapy (group 1) and 80 eyes of 40 healthy controls (group 2) were included in this prospective cohort study. The structure of the choroid was evaluated using enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT) and choroidal binarisation. Spectral-domain OCT (SD-OCT) was performed to analyse the peripapillary nerve fibre layer thickness (pRNFL) and each retinal layer thickness. A subgroup analysis was performed based on chemotherapy history in Group 1. All parameters were compared between Group 1 and the healthy controls and between the subgroups of Group 1. RESULTS The subfoveal choroidal thickness and temporal and nasal directions were increased in Group 1 when compared with Group 2 (p < 0.05, each comparison). Choroidal vascularity index was significantly decreased in Group 1 compared with Group 2 (63.15 ± 3.11% and 65.37 ± 4.63%, p < 0.001). There were no significant differences in each retinal layer, pRNFL thickness, and choroid structural parameters between the subgroups of Group 1. CONCLUSIONS Increased choroidal thickness may be the initial finding of subclinical tamoxifen-induced retinopathy. Patients with breast cancer undergoing tamoxifen therapy may be screened prior to tamoxifen therapy and followed during treatment by SD-OCT.
Collapse
Affiliation(s)
| | - Vehbi Açıkgöz
- Ministry of Health Ankara City Hospital, Ophthalmology Clinic, Ankara, Turkey
| | - Nagihan Uğurlu
- Ministry of Health Ankara City Hospital, Ophthalmology Clinic, Ankara, Turkey
| | - Bülent Yalçın
- Ministry of Health Ankara City Hospital, Oncology Clinic, Ankara, Turkey
| | | | - Mutlu Hızal
- Ministry of Health Ankara City Hospital, Oncology Clinic, Ankara, Turkey
| | - Halil Kara
- Department of Pharmocology, Yıldırım Beyazıt University, Ankara, Turkey
| |
Collapse
|
3
|
Sohn A, Sanchez G, Mantopoulos D. Partial thickness subfoveal hole in a patient treated with tamoxifen: a case report and review of the literature. J Med Case Rep 2022; 16:471. [PMID: 36539911 PMCID: PMC9769049 DOI: 10.1186/s13256-022-03681-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Accepted: 11/18/2022] [Indexed: 12/24/2022] Open
Abstract
BACKGROUND We describe a patient presenting with a partial thickness subfoveal hole in the right eye after tamoxifen treatment for breast cancer. CASE PRESENTATION A 76-year-old Caucasian female presented with a 1-day history of acute central scotoma and blurry vision in the right eye. The patient had been receiving oral tamoxifen for 5 years as adjuvant treatment for stage I lobular breast cancer. Her past ocular history was significant for complete, uneventful, and bilateral posterior vitreous detachment. Clinical examination and optical coherence tomography revealed a new, partial thickness subfoveal hole sparing the inner retinal layers. Observation was recommended. At the last follow-up examination, 1 year after the initial presentation, the subfoveal hole remained stable and visual acuity remained stable. CONCLUSION Tamoxifen has been associated with a plethora of ophthalmic adverse events, including macular holes, some of which are partial thickness subfoveal holes. Holes with this almost unique morphology are uncommon, and eye care professionals should be aware of this association given the frequency of tamoxifen use, as well as the low success rate of surgical repair with pars plana vitrectomy.
Collapse
Affiliation(s)
- Ashley Sohn
- grid.254880.30000 0001 2179 2404Geisel School of Medicine at Dartmouth, Hanover, NH USA
| | - George Sanchez
- grid.254880.30000 0001 2179 2404Geisel School of Medicine at Dartmouth, Hanover, NH USA
| | - Dimosthenis Mantopoulos
- grid.254880.30000 0001 2179 2404Geisel School of Medicine at Dartmouth, Hanover, NH USA ,grid.413480.a0000 0004 0440 749XDepartment of Ophthalmology, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756 USA
| |
Collapse
|
4
|
Torrell Belzach N, Vela Segarra JI, Crespí Vilimelis J, Alhayek M. Bilateral Macular Hole Related to Tamoxifen Low-Dose Toxicity. Case Rep Ophthalmol 2020; 11:528-533. [PMID: 33173501 PMCID: PMC7588700 DOI: 10.1159/000508327] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2020] [Accepted: 04/30/2020] [Indexed: 12/21/2022] Open
Abstract
Bilateral macular hole is a rare secondary effect of tamoxifen, a condition which is probably underdiagnosed. We describe the case of a 63-year-old woman who had received low-dose treatment with tamoxifen for 10 years. She presented with a best-corrected visual acuity of 20/40 in both eyes and bilateral macular hole with posterior hyaloid attachment. No reflective deposits were observed. A 23-gauge pars plana vitrectomy with internal limiting membrane peeling and gas tamponade was performed in the right eye with no anatomical or functional improvement. The most accepted mechanism of macular hole related to tamoxifen is Müller cell toxicity with retinal tissue loss. Therefore, it seems that the standard procedure used in idiopathic macular hole is not the optimal choice, due to a different pathogenic mechanism.
Collapse
Affiliation(s)
| | - José Ignacio Vela Segarra
- Department of Ophthalmology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.,Institut Condal d'Oftalmologia, Barcelona, Spain.,Autonomous University of Barcelona, Barcelona, Spain
| | - Jaume Crespí Vilimelis
- Department of Ophthalmology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.,Institut Condal d'Oftalmologia, Barcelona, Spain
| | - Mohammed Alhayek
- Department of Ophthalmology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| |
Collapse
|
5
|
|
6
|
Doshi RR, Fortun JA, Kim BT, Dubovy SR, Rosenfeld PJ. Pseudocystic foveal cavitation in tamoxifen retinopathy. Am J Ophthalmol 2014; 157:1291-1298.e3. [PMID: 24582991 DOI: 10.1016/j.ajo.2014.02.046] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2013] [Revised: 02/21/2014] [Accepted: 02/21/2014] [Indexed: 11/26/2022]
Abstract
PURPOSE To present 3 cases of tamoxifen-induced foveal cavitation and review previous prospective and cross-sectional studies. DESIGN Observational case series. METHODS Retrospective analysis of patients presenting to a single institution with evidence of tamoxifen-induced maculopathy. RESULTS Three patients presented with pseudocystic foveal cavitation similar in appearance to macular telangiectasia type 2 on spectral-domain optical coherence tomography (SD OCT) imaging. CONCLUSIONS Tamoxifen maculopathy is characterized by cavitation in the central macula with or without typical cystoid macular edema. Pathogenesis involves toxicity to retinal Müller cells. It can occur with low daily and cumulative doses of the drug, and in the absence of subjective visual complaints or crystalline retinopathy. Prospective research with SD OCT imaging will be required to gain a more accurate estimate of the incidence of tamoxifen retinopathy.
Collapse
|
7
|
Caramoy A, Scholz P, Fauser S, Kirchhof B. Imaging tamoxifen retinopathy using spectral-domain optical coherence tomography. GMS OPHTHALMOLOGY CASES 2011; 1:Doc07. [PMID: 27625929 PMCID: PMC5015609 DOI: 10.3205/oc000007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
A case of tamoxifen retinopathy examined with spectral-domain optical coherence tomography (SD-OCT) is presented. The typical refractile deposits are located between ganglion cell layer and inner plexiform layer in SD-OCT. A defect on the outer retinal layer with disruption of the photoreceptor layer with sharp edges is seen. The still attached posterior hyaloids gives evidence of other pathomechanism involved in the outer retinal defect than that of macular hole, as suggested in the literature.
Collapse
Affiliation(s)
- Albert Caramoy
- University of Cologne, Center of Ophthalmology, Department of Vitreo-Retinal Surgery, Cologne, Germany
| | - Paula Scholz
- University of Cologne, Center of Ophthalmology, Department of Vitreo-Retinal Surgery, Cologne, Germany
| | - Sascha Fauser
- University of Cologne, Center of Ophthalmology, Department of Vitreo-Retinal Surgery, Cologne, Germany
| | - Bernd Kirchhof
- University of Cologne, Center of Ophthalmology, Department of Vitreo-Retinal Surgery, Cologne, Germany
| |
Collapse
|
8
|
Chung SE, Kim SW, Chung HW, Kang SW. Estrogen antagonist and development of macular hole. KOREAN JOURNAL OF OPHTHALMOLOGY 2010; 24:306-9. [PMID: 21052512 PMCID: PMC2955275 DOI: 10.3341/kjo.2010.24.5.306] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2009] [Accepted: 12/08/2009] [Indexed: 11/23/2022] Open
Abstract
To describe the clinical and optical coherence tomography (OCT) features of a macular hole (MH) or its precursor lesion in patients treated with systemic antiestrogen agents. We reviewed the medical history of the patient, ophthalmic examination, and both fundus and OCT findings. Three female patients receiving antiestrogen therapy sought treatment for visual disturbance. All of the patients showed foveal cystic changes with outer retinal defect upon OCT. Visual improvement was achieved through surgery for the treatment of MH in two patients. Antiestrogen therapy may result in MH or its precursor lesion, in addition to perifoveal refractile deposits. OCT examination would be helpful for early detection in such cases.
Collapse
Affiliation(s)
- Song Ee Chung
- Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | | | | | | |
Collapse
|
9
|
Watanabe SES, Berezovsky A, Motono M, Sacai PY, Pereira JM, Sallum JMF, Gebrim LH, Salomão SR. Retinal function in patients treated with tamoxifen. Doc Ophthalmol 2010; 120:137-43. [PMID: 19911210 DOI: 10.1007/s10633-009-9203-8] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2009] [Accepted: 10/12/2009] [Indexed: 10/20/2022]
Abstract
Tamoxifen, an effective treatment of breast cancer, has been shown to cause ocular toxic effects. The purpose of this study was to determine retinal toxicity by full-field and focal electroretinograms (ERGs) in patients treated with tamoxifen. Fullfield and focal ERGs were obtained from three groups: Tamoxifen-14 females (47-72 years, mean 58.3 + or - 9.1) with normal fundus, treated with tamoxifen from 2 to 37 months; No Treatment-10 females (39-65 years, mean 50.1 + or - 8.7) with previous breast cancer diagnosis and before tamoxifen treatment; Control-13 normal female volunteers (41-81 years, mean 52.7 + or - 12.1). Peak-to-peak amplitude and b-wave implicit time were measured and statistically analyzed.Mean peak-to-peak amplitudes and implicit time from full-field and focal ERGs were comparable for the three different groups. Low-dosage tamoxifen showed no retinotoxic effect assessed by full-field and focal ERG in this small group of women with breast cancer.
Collapse
Affiliation(s)
- Sung Eun Song Watanabe
- Deptartment of Ophthalmology, Federal University of São Paulo, UNIFESP, São Paulo, Brazil.
| | | | | | | | | | | | | | | |
Collapse
|
10
|
|
11
|
Bhatia A, Singh B, Bhushan S, Katare OP. Tamoxifen-encapsulated vesicular systems: cytotoxicity evaluation in human epidermal keratinocyte cell line. Drug Dev Ind Pharm 2010. [DOI: 10.3109/03639040903173549] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
12
|
Bhatia A, Bhushan S, Singh B, Katare OP. Studies on tamoxifen encapsulated in lipid vesicles: effect on the growth of human breast cancer MCF-7 cells. J Liposome Res 2009; 19:169-72. [PMID: 18991067 DOI: 10.1080/08982100802518574] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Tamoxifen is a nonsteroidal estrogen-receptor modulator widely used in the treatment of breast cancer. Apoptosis has been reported to be a major mechanism for its antitumor effect. In the current studies, an endeavor was made to investigate the efficacy of vesicularly encapsulated tamoxifen on human breast cancer MCF-7 cells. Phospholipid-based vesicular systems viz. conventional liposomes and elastic-membrane liposomes were employed to encapsulate the drug. The MTT colorimetric assay was used to determine the efficacy of the tested formulations. The results demonstrated composition-dependent strong inhibition in the viability of MCF-7 cells with encapsulated tamoxifen vis-à-vis free drug. The encouraging findings from the current work construe immense potential of the lipid-based vesicular systems in the treatment of breast cancer.
Collapse
Affiliation(s)
- Amit Bhatia
- Drug Delivery Research Group, University Institute of Pharmaceutical Sciences-UGC Centre of Advanced Study, Panjab University, Chandigarh, India
| | | | | | | |
Collapse
|
13
|
Charbel Issa P, van der Veen RL, Stijfs A, Holz FG, Scholl HP, Berendschot TT. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. Exp Eye Res 2009; 89:25-31. [DOI: 10.1016/j.exer.2009.02.006] [Citation(s) in RCA: 60] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2008] [Revised: 02/09/2009] [Accepted: 02/09/2009] [Indexed: 10/21/2022]
|
14
|
Abstract
Cancer survivorship is an emerging area of scientific and clinical interest. Several decades ago, most people diagnosed with cancer did not live long beyond their initial diagnosis. Today the number of cancer survivors exceeds ten million, and this group may experience unique healthcare issues related to their cancer treatment. Chemotherapy, surgery, and radiation therapy each have their own late and long-term complications. It is imperative for clinicians who are caring for cancer survivors to be aware of long-term complications of therapy and to treat these appropriately. When cancer therapy has successfully added years of life, it is equally as important that medical care assures the best quality of life during those years.
Collapse
Affiliation(s)
- Kenneth D Miller
- Department of Medical Oncology Yale Cancer Center, New Haven, CT, USA.
| | | |
Collapse
|